Inactive

Title BD Biosciences Proprietary Reagent Kits for the Center for Cellular Engineering (CCE) Product Service Code: 6550 NAICS Code: 334516 Place of Performance: Bethesda, MD 20892 USA POTS: 24-011554 D... Title BD Biosciences Proprietary Reagent Kits for the Center for Cellular Engineering (CCE) Product Service Code: 6550 NAICS Code: 334516 Place of Performance: Bethesda, MD 20892 USA POTS: 24-011554 Description This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health (NIH) intends to award a fixed price purchase order to procure BD Rhapsody™ single cell AbSeq reagent kits from Becton. Dickinson, & Company of San Jose, California 95131-1807. These kits will be used for an ongoing study of single cell CITE-seq performed in the PACT section of Center of Cellular Engineering. Key Features and Benefits for BD™ AbSeq reagent kits: The purpose of these kits is to provide the necessary reagents for the preparation of single cell mRNA, Sample Tag, multiplexing, targeted Immune response panel and BD™ AbSeq libraries with the BD Rhapsody™ Single-Cell Analysis system or the BD Rhapsody™ Express Single-Cell Analysis system. The BD Rhapsody™ AbSeq Immune Discovery Panel reagent kit from BD Biosciences delivers the power of high-throughput single-cell of AbSeq libraries generation on a benchtop system with increased stability and robustness. The kit delivers powerful sequencing library construction chemistries with as little of hands-on time. Intuitive labeling and RFID-encoded reagents ensure compatibility with user-defined run configurations. Ready-to-use cartridges redefine ease-of-use. BD Biosciences is the sole manufacturer and trademark holder of the specified proprietary reagent kits which are the only known reagents compatible with the existing BD Rhapsody™ single cell analysis system currently located in the Center for Cellular Engineering lab. The below items are required for this request: Catalog Number/Description/Quantity 633750/ Rhapsody Immune Response Panel HS.3 Quotes# BDB 2024-97348 v1, BDB 2024-97350 v1 and BDB 2024-97351 v1/5 665913/ Rhapsody Targeted mRNA AbSeq Kit 4 Pack.3 Quotes# BDB 2024-97348 v1, BDB 2024-97350 v1 and BDB 2024-97351 v1/5 633781/ Ab-O Single Cell Sample Multiplexing Kit.3 Quotes# BDB 2024-97348 v1, BDB 2024-97350 v1 and BDB 2024-97351 v1/5 625970/ BD AbSeq Immune Discovery Panel CTT LYO.3 Quotes# BDB 2024-97348 v1, BDB 2024-97350 v1 and BDB 2024-97351 v1/5 Shipping and Handling This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. The total dollar value of this requirement shall not exceed the Simplified Acquisition Threshold (SAT) $250,000.00. Interested parties may identify their interest and submit capability statements in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by August 22, 2024, 6:30AM EST. *** Please send your capability statements ONLY. This IS NOT a request for quotation. ***